Join
Live feed
·
INSIDERFilingvia Quantisnow
TCR2 Therapeutics Inc. logo

SEC Form 4: Olagunju Peter converted options into 33,409 shares and sold $1,766 worth of shares (1,273 units at $1.39) as part of a pre-agreed trading plan, increasing direct ownership by 1,466% to 34,328 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRR (TCR2 Therapeutics Inc.) and more on Quantisnow.